Biotech Values

[ilpapa]

SGEN report was well received by the pre-market.
(Does the tag at the end mean the piece was untouched by human hand?)

BOTHELL, Wash. (AP) _ Seattle Genetics Inc. (SGEN) on Thursday reported a third-quarter loss of $15.6 million.

On a per-share basis, the Bothell, Washington-based company said it had a loss of 13 cents.

The results beat Wall Street expectations. The average estimate of analysts surveyed by Zacks Investment Research was for a loss of 25 cents per share.

The biotechnology company posted revenue of $75.9 million in the period, also exceeding Street forecasts. Analysts expected $66.7 million, according to Zacks.

Seattle Genetics shares have decreased 12 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $35.25, a decline of 12 percent in the last 12 months.

_____

This story was generated by Automated Insights using data from Zacks Investment Research. SGEN stock research report from Zacks.